Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering/IBA set up UK PET (positron emission tomography) imaging radiotracer company:

This article was originally published in Clinica

Executive Summary

Schering AG's UK business, Schering Health Care, has teamed up with IBA of Belgium to form a new UK company for the supply of a positron emission tomography (PET) imaging radiotracer. UK Radiopharma will be the country's first commercially licensed supplier of F-18 fluodeoxyglucose (FDG), which it will sell as Flucis. Market launch is expected by 2005. Schering AG and IBA (which already sells FDG in the US) plan eventually to create a European network of FDG production sites. FDG is the most commonly used radioactive tracer used in PET imaging for cancer diagnosis and treatment monitoring.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063386

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel